| Inhibitory immune checkpoint (ICP) molecules are important immunosuppressive
factors in a tumor microenvironment (TME). They can robustly suppress T‐cellmediated
antitumor immune responses leading to cancer progression. Among the
checkpoint molecules, cytotoxic T‐lymphocyte‐associated protein‐4 (CTLA‐4) is one
of the critical inhibitors of anticancer T‐cell responses. Besides, the expression of
adenosine receptor (A2AR) on tumor‐infiltrating T cells potently reduces their
function. We hypothesized that concomitant silencing of these molecules in T cells
might lead to enhanced antitumor responses. To examine this assumption, we
purified T cells from the tumor, spleen, and local lymph nodes of CT26 colon
cancer‐bearing mice and suppressed the expression of A2AR and CTLA‐4 using the
small interfering RNA (siRNA)‐loaded polyethylene glycol‐chitosan‐alginate (PCA)
nanoparticles. The appropriate physicochemical properties of the produced nanoparticles
(NPs; size of 72 nm, polydispersive index [PDI] < 0.2, and zeta potential of
11 mV) resulted in their high efficiency in transfection and suppression of target
gene expression. Following the silencing of checkpoint molecules, various T‐cell
functions, including proliferation, apoptosis, cytokine secretion, differentiation, and
cytotoxicity were analyzed, ex vivo. The results showed that the generated nanoparticles
had optimal physicochemical characteristics and significantly suppressed
the expression of target molecules in T cells. Moreover, a concomitant blockade of
A2AR and CTLA‐4 in T cells could synergistically enhance antitumor responses
through the downregulation of PKA, SHP2, and PP2Aα signaling pathways. Therefore,
this combination therapy can be considered as a novel promising anticancer
therapeutic strategy, which should be further investigated in subsequent studies. |